What is the rating for FCUV stock?

FOCUS UNIVERSAL INC. (FCUV) has a "Avoid" rating based on our 6-factor quantitative model. It has a composite score of 38.9 and ranks #3684 out of 7,333 stocks in our coverage universe with a 1-star rating.

Is FCUV a good stock to buy?

Based on our quantitative analysis, FCUV receives a "Avoid" rating with 1 out of 5 stars. Key factors include: Quality score of 24.1, Value score of 35.6, and Momentum score of 47. The timing score is 62, indicating "Bullish" entry conditions. This is not investment advice - please conduct your own research.

What sector is FCUV in?

FOCUS UNIVERSAL INC. (FCUV) operates in the Manufacturing sector, specifically in the Measuring And Control Equipment industry. It has a market capitalization of $0.02 billion.

What is FCUV's P/E ratio?

P/E ratio data is not currently available for FCUV.

Does FCUV pay a dividend?

FCUV does not currently pay a dividend.

What is FCUV's market cap?

FOCUS UNIVERSAL INC. (FCUV) has a market capitalization of $0.02 billion, making it a micro-cap stock.

What are the risks of investing in FCUV?

Key risk factors for FCUV include: higher volatility, elevated debt levels, and general market risk. As with all investments, there is risk of loss.

How does FCUV compare to peers?

Within the Manufacturing sector, FCUV ranks #3684 overall with a quality score of 24.1/100 and value score of 35.6/100.

What is FCUV's revenue growth?

FCUV has revenue growth of 45.2% year-over-year.

What is FCUV's composite score?

FOCUS UNIVERSAL INC. (FCUV) has a composite score of 38.9/100, which places it at rank #3684 out of 7,333 stocks. This score is derived from our proprietary 6-factor quantitative model that evaluates quality, value, momentum, investment efficiency, stability, and short interest.

How does FCUV compare to the S&P 500?

FCUV ranks in the top 50% of all stocks in our coverage universe with a composite score of 38.9. This places it below the market median.

What are the bull and bear cases for FCUV?

Bull case: FCUV scores highest in momentum at 47/100, indicating strong performance in this area. Bear case: The weakest factor is stability at 5.7/100, which may present a risk. Our overall assessment is Avoid with 1 out of 5 stars.

Is FCUV overvalued or undervalued?

FCUV appears overvalued based on our value factor score of 35.6/100.

What is FCUV's momentum score?

FCUV has a momentum score of 47/100, placing it in the moderate category.

When is FCUV's next earnings date?

For the latest earnings date and analysis for FCUV, visit our earnings calendar or check the FCUV stock page for real-time updates. Our AI-generated earnings reports provide in-depth analysis after each quarterly report.

Is FCUV a good stock to buy right now?

Based on our 6-factor quantitative model, FOCUS UNIVERSAL INC. (FCUV) receives a "Avoid" rating with a composite score of 38.9/100. It is ranked #3684 out of 7,333 stocks. Key factor scores: Quality 24/100, Value 36/100, Momentum 47/100. The timing signal is "Bullish". This is quantitative analysis only — not investment advice.

What is the stock rating for FCUV?

FOCUS UNIVERSAL INC. (FCUV) has a "Avoid" rating and 1-star score. The composite score of 38.9 ranks it #3684 among 7,333 U.S. stocks. Ratings are updated weekly using academically-proven factor models.

What sector is FCUV in?

FOCUS UNIVERSAL INC. operates in the Manufacturing sector (Measuring And Control Equipment industry) with a market cap of $23 million. It is classified as a micro-cap stock.

Does FCUV pay a dividend?

FCUV does not currently pay a regular dividend. The company may be reinvesting profits for growth.

What is FCUV's P/E ratio?

P/E ratio data is not currently available for FCUV, which may indicate the company is not yet profitable.

How profitable is FCUV?

FCUV's quality factor score is 24/100. Gross margin: 4.5%. ROE: -1419.5% vs sector average -1.9%. Margins are moderate to low, reflecting competitive market dynamics.

How is FCUV valued compared to peers?

FCUV's value factor score is 36/100 (higher = cheaper). Key multiples: . Trading at a premium relative to peers.

What is FCUV's debt level?

FCUV's debt-to-equity ratio is 404%. Sector average: 0%. Elevated leverage increases credit risk.

FCUV has a beta of 2.85, meaning it amplifies market moves. Stability score: 6/100.

Does FCUV have high short interest?

FCUV's short interest factor score is 46/100 (higher = less short selling). Elevated short interest may indicate bearish sentiment or short squeeze potential.

FCUV Stock Analysis — FOCUS UNIVERSAL INC. Price Target & Forecast 2026

IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.

HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.

RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.

FCUV Stock Analysis — FOCUS UNIVERSAL INC. Price Target & Forecast 2026 | Blank Capital Research

Sector

Manufacturing

Industry

Measuring And Control Equipment

Market Cap

$23M

Leadership

Desheng Wang

Business Summary

Focus Universal Inc. develops and manufactures smart instrumentation platform and device. It offers Ubiquitor, a wireless sensor device with a universal sensor node and gateway system that uses a computer or mobile device as the output display module that displays the readings of various sensor nodes. It also offers digital sensors and horticultural sensors.

Operations

Headcount

Location

HQ Base

Pending Verification

Investor Relations

Fundamental Spot Check

Context: 2025

Valuation

Market Cap

$23M

P/E Ratio

P/B Ratio

31.55xLagging

P/S Ratio

16.79xLagging

EV/EBITDA

Dividend Yield

0.00%

Efficiency & Risk

Gross Margin

4.5%Lagging

Operating Margin

-2875.8%Lagging

ROE

-1419.5%Lagging

Rev Growth (YoY)

45.2%

Debt/Equity

404.00xLagging

Beta

2.85

Red = Sector Laggard

Black = Market Average

Revenue Breakdown

Strategic Timing Audit

WEAK

0/6

Negative Alignment — Extreme Caution

Quantitative Factor Convergence Analysis Verified

Momentum

47th pctl

Intelligence Feed

yahooDec 26 Negative

Focus Universal Inc. Launches Cost-Effective Commercial IoT for Four Sectors

ONTARIO, CA - December 26, 2025 (NEWMEDIAWIRE) - Focus Universal Inc. (NASDAQ: FCUV) ("Focus" or the "Company"), a provider of patented hardware and software design technologies for the Internet of Things (IoT), 5G, and AI-driven automation software ...

finance.yahoo.comDec 26 Positive

Focus Universal Inc. Forms Sales Division for IoT and SEC Financial Reporting Solutions

finance.yahoo.comDec 23 Neutral

Focus Universal Inc. Regains Compliance With Nasdaq Listing Requirements

ONTARIO, CA - December 23, 2025 (NEWMEDIAWIRE) - Focus Universal Inc. (NASDAQ: FCUV) ("Focus" or the "Company"), a provider of patented hardware and software design technologies for Internet of Things (IoT), 5G and SEC Financial Reporting AI-Driven A...

BenzingaApr 9 Neutral

Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket

Shares of Biophytis S.A. (NASDAQ: BPTS) rose sharply in today’s pre-market trading after reporting FY23 results. Biophytis posted a FY23 loss of €0.03 per share, versus a year-ago loss of €0.14 per share, according to data from Benzinga Pro. Biophytis shares jumped 55.2% to $0.4920 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers MyMD Pharmaceuticals, Inc. (NASDAQ: MYMD) shares rose 40% to $3.64 in pre-market trading after jumping 22% on Monday. MediaCo Holding Inc. (NASDAQ: MDIA) shares rose 20.2% to $3.63 in pre-market trading after falling 22% on Monday. On April 4, an SEC filing showed Standard General L.P. reported a 95.2% stake in the company, as of April 1. Destiny Tech100 Inc. (NASDAQ: DXYZ) gained 18.5% to $118.33 in pre-market trading after jumping over 68% on Monday. Addex Therapeutics Ltd (NASDAQ: ADXN) shares gained 17.2% to $25.60 in pre-market trading after jumping around 21% on Monday. Addex Therapeutics and funds affiliated with Perceptive ...

BenzingaDec 16 Positive

Why Avaya Holdings Shares Are Trading Lower By 62%? Here Are 62 Stocks Moving In Friday's Mid-Day Session

Gainers Allarity Therapeutics, Inc. (NASDAQ: ALLR) gained 240% to $0.90. Allarity Therapeutics, last month, posted a Q3 loss of $0.68 per share. Maxar Technologies Inc. (NYSE: MAXR) shares jumped 120.2% to $50.86 after the company announced it will be acquired by Advent International for $6.4 billion. Trean Insurance Group, Inc. (NASDAQ: TIG) gained 92.2% to $6.00 after the company announced a definitive agreement to be acquired by Altaris Capital Partners for $6.15 per share in cash. Dermata Therapeutics, Inc. (NASDAQ: DRMA) jumped 82% to $0.3549. Dermata Therapeutics recently announced topline results from its DMT310 Phase 2 trial, which did not meet primary endpoints. BeyondSpring Inc. (NASDAQ: BYSI) gained 39% to $2.1286. BeyondSpring recently presented data with plinabulin for the prevention of docetaxel-induced neutropenia in patients with non-small cell lung cancer and breast cancer at three medical conferences. Minim, Inc. (NASDAQ: MINM) shares gained 32.5% to $0.2315 after gaining over 10% on Thursday. Minim, last month, reported worse-than-expected results. authID Inc. (NASDAQ: AUID) gained 24.8% to $0.8995. Ambrx Biopharma Inc. (NYSE: AMAM) jumped 23.2% to $2.7775. Exact Sciences Corporation (NASDAQ: EXAS) shares gained 23.1% to $54.90 after competitor Guardant Health reported results from a study of its colorectal cancer detection blood test. Future FinTech Group Inc. (NASDAQ: FTFT) jumped 21.7% to $0.4410 Nocera, Inc. (NASDAQ: NCRA) gained 20.8% to $1.51. Adagene Inc. (NASDAQ: ADAG) jumped 19.8% to $1.5818. Adagene announced clinical trial collaboration to evaluate anti-CTLA-4 SAFEbody ADG126 in combination with Roche's standard-of-care for first-line advanced liver cancer. COMSovereign Holding Corp. (NASDAQ: COMS) rose 18.8% to $0.0870. Recruiter.com Group, Inc. (NASDAQ: RCRT) jumped 17.4% to $0.44. Applied UV, Inc. (NASDAQ: AUVI) gained 17% to $1.12 after the company announced it signed a strategic manufacturing and related services agreement with Canon Virginia. Lanvin Group (NASDAQ: LANV) shares gained 17% to $8.93 after dropping over 22% on Thursday. Crown ElectroKinetics Corp. (NASDAQ: CRKN) climbed 16.8% to $0.2146 after jumping around 20% on Thursday. Gelesis Holdings, Inc. (NYSE: GLS) rose 16.5% to $0.2601. United Insurance Holdings Corp. (NASDAQ:

Earnings Call Transcripts

Unlock Valuation Tools

Get full access to institutional-quality research tools with Blank Capital Pro.

Upgrade to Pro

Starting at $19.99/mo

Financial Intelligence Ledger

Verified SEC Filings Aggregate • FCUV

Export

Metric Entity	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Revenue	$398K62.2%	$1M197.6%	$354K75.3%	$1M14.6%	$2M15.0%	$1M373.9%	$308K65.7%	$898K166.1%	$337K	$20K
Cost of Revenue	$388K59.5%	$958K189.6%	$331K	—	$1M4.0%	$1M873.3%	$138K81.0%	$726K	$57K433.9%	$11K
Gross Profit	$10K89.1%	$94K312.8%	$23K	—	$284K140.0%	$118K30.5%	$170K0.9%	$172K38.7%	$280K	$9K
R&D Expense	$1M0.4%	$1M30.8%	$1M381.0%	$220K14.1%	$257K0.6%	$255K15.2%	$222K6.4%	$208K3.1%	$202K	—
Operating Expenses	$6M22.8%	$5M3.3%	$5M	—	$3M13.4%	$3M96.6%	$2M153.6%	$692K4.4%	$724K671.5%	$94K
Operating Income	-$6M24.9%	-$5M4.7%	-$5M72.6%	-$3M11.6%	-$3M18.8%	-$3M110.3%	-$2M204.7%	-$520K17.3%	-$443K425.5%	-$84K
Interest Expense	—	—	—	$38K823.5%	$4K919.1%	-$507100.1%	$441K316.7%	$106K	$203	—
Tax Provision	$0	$0	$0	$0	$0	$0	—	$69456.6%	$2K	$0
EBITDA	-$6M24.9%	-$5M4.7%	-$5M72.6%	-$3M27.1%	-$2M21.3%	-$3M147.4%	-$1M178.9%	-$437K6.2%	-$466K452.4%	-$84K
Net Income	-$3M32.2%	-$5M4.2%	-$5M53.0%	-$3M27.0%	-$3M20.1%	-$3M56.8%	-$2M223.2%	-$626K42.1%	-$441K422.8%	-$84K
EPS (Diluted)	$-0.48500.0%	$-0.0827.3%	$-0.11	-	$-0.0625.0%	$-0.0860.0%	$-0.05150.0%	$-0.02100.0%	$-0.010.0%	$-0.01

SEC EDGAR Repository

Direct unfiltered access to 10-K, 10-Q and 8-K filings for FCUV.

Open Regulatory Dossier

Data Integrity Notice

Figures adjusted for stock splits and restatements where applicable.

TTM (Trailing Twelve Months) data updates within 48 hours of quarterly filings.

Execution Benchmarks Audit

Revenue Growth

YOY expansion rate

+579% SCTR

45.2%

Sector Avg: 6.7%

Gross Margin

Core pricing power

-90% SCTR

4.5%

Sector Avg: 44.1%

Operating Margin

Operating efficiency

-114674% SCTR

-2875.8%

Sector Avg: 2.5%

Return on Equity

Equity efficiency

+74613% SCTR

-1419.5%

Sector Avg: -1.9%

Debt/Equity

Financial leverage

-192281% SCTR

404.0%

Sector Avg: 0.2%

Dividend Yield

Direct cash return

-NaN% SCTR

0.0%

Sector Avg: 0.0%

Financial History

Forensic Accounting Audit

Audit Required

Asset Efficiencymedium RISK

Material decline in asset turnover efficiency detected

Margin Integritymedium RISK

High margin volatility — erratic forensic earnings quality

Algorithmic red flag detection based on regulatory SEC filings.

Unlock Financial Statements

Get full access to institutional-quality research tools with Blank Capital Pro.

Upgrade to Pro

Starting at $19.99/mo

Shareholder Returns

Capital Allocation audit

Smart Money Conviction

Neutral

Synthesized from recent 13F filings, Form 4 insider transactions, and outstanding short interest metrics.

Governance Audit

Weak Index

WeakModerateStrong

Lower quality and stability scores may indicate governance concerns. Verified against factor-based integrity benchmarks.

Executive Operations

CEO: Desheng Wang

Insider alignment Audit

No recent insider transactions available for FCUV

Major Institutional Blocks

Top 5 Holders

Institutional cap table data requires verified 13F filing feeds.

Access SEC 13F Dossier →

Form 4 Filings

Recent Activity

Insider transaction data currently awaiting regulatory verification.

Access SEC Form 4 Dossier →

Regulatory Disclosure Vault

Proxy Statement (DEF 14A)

Exec Comp, Board Nominees, Proposals

Annual Report (10-K)

MD&A, Risk Factors, Strategy

Institutional Holders (13F)

Loading institutional data...

Insider Liquidity

Short Interest audit

SEC Risk Factors

Unlock Governance & Ownership

Get full access to institutional-quality research tools with Blank Capital Pro.

Upgrade to Pro

Starting at $19.99/mo

Unlock Factor Analysis

Get full access to institutional-quality research tools with Blank Capital Pro.

Upgrade to Pro

Starting at $19.99/mo

Unlock Investment Thesis

Get full access to institutional-quality research tools with Blank Capital Pro.

Upgrade to Pro

Starting at $19.99/mo

Institutional Peer Matrix

Top Manufacturing Universe

Stock	Rating	Score▼	Quality	Value	Momentum	P/E	EV/EBITDA	ROE	ROA	Gross Mgn	Op Mgn	Net Mgn	Rev Growth	Div Yield	D/E	Mkt Cap	AUDIT
$UL UNILEVER PLC		78	96	98	59	-	-	-	-	-	-	-	-	-	-	$0	VS
$ASML ASML HOLDING NV		77	89	86	83	-	-	-	-	-	-	-	-	-	-	$0	VS
$ESLT ELBIT SYSTEMS LTD		76	81	87	85	-	-	-	-	-	-	-	-	-	-	$0	VS
$MT ArcelorMittal		75	71	98	85	-	-	-	-	-	-	-	-	-	-	$0	VS
$AMAT APPLIED MATERIALS INC /DE		75	85	87	84	20.9x	13.6x	32.9%	20.5%	48.8%	30.6%	24.4%	7.7%	0.9%	32.0x	$148.6B	VS
$SIMO Silicon Motion Technology CORP		75	84	86	85	-	-	-	-	-	-	-	-	-	-	$0	VS
$CODA Coda Octopus Group, Inc.		74	83	90	79	16.3x	11.9x	7.4%	7.5%	68.3%	19.5%	18.2%	29.0%	0.0%	0.0x	$84M	VS
$GSK GSK plc		74	84	90	70	-	-	-	-	-	-	-	-	-	-	$0	VS
$EFXT Enerflex Ltd.		74	80	91	83	-	-	-	-	-	-	-	-	-	-	$0	VS
$BUD Anheuser-Busch InBev SA/NV		74	84	97	63	-	-	-	-	-	-	-	-	-	-	$0	VS
$FCUV FOCUS UNIVERSAL INC.		39	24	36	47	-	-	-1419.5%	-281.8%	4.5%	-2875.8%	-1760.5%	45.2%	0.0%	404.0x	$23M
SECTOR BENCH	-	-	-	-	-	22.3x	11.5x	-1.9%	0.9%	44.1%	2.5%	1.0%	6.7%	0.0%	0.2x	-	REF

Access Full Manufacturing Intelligence Archive →

Lateral Comparison Mesh

$FCUV / $UL AUDIT $FCUV / $ASML AUDIT $FCUV / $ESLT AUDIT $FCUV / $MT AUDIT $FCUV / $AMAT AUDIT

Market Intelligence FAQ

FOCUS UNIVERSAL INC. (FCUV) receives a "Avoid" rating with a composite score of 38.9/100. It ranks #3684 out of 7,333 stocks in our coverage universe and carries a 1-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.

Full Research Publication

Equity Research Analysis: FOCUS UNIVERSAL INC. (FCUV)

FEBRUARY 2026|Blank Capital Research Unit|Spot: $5.04

Price$5.04

Composite Score38.9/100

RatingAVOID (1★)

Rank#3684 OF 7,333

Market Cap$23M

Comments

Institutional Audit

Feb 25, 2026

FOCUS UNIVERSAL INC.

38.9

Executive Summary

Our quantitative model flags FOCUS UNIVERSAL INC. with an Avoid rating, assigning a composite score of 38.9/100 and 1 out of 5 stars. Ranked #3684 of 7,333 stocks, FCUV falls in the bottom tier across key factors. Historically, stocks with this profile have faced elevated risk of underperformance and capital loss.

Business Quality

FOCUS UNIVERSAL INC. registers a weak quality score of just 24/100, indicating significant profitability challenges. The company reports a return on equity of -1419.5% (sector avg: -1.9%), gross margins of 4.5% (sector avg: 44.1%), net margins of -1760.5% (sector avg: 1.0%). Low quality scores are often associated with businesses in turnaround mode, early-stage growth, or structurally challenged industries.

Intrinsic Valuation

With a value score of 36/100, FCUV appears somewhat expensive relative to its fundamentals. Key valuation metrics include a P/B ratio of 31.55x. Investors paying a premium here are likely betting on above-average growth or margin expansion to justify current prices.

Capital Reinvestment

FOCUS UNIVERSAL INC.'s investment score of 35/100 suggests limited reinvestment activity. Key growth metrics include revenue growth of 45.2% vs. a sector average of 6.7% and a return on assets of -281.8% (sector: 0.9%). While this can be positive for mature, cash-generative businesses returning capital to shareholders, it may also signal a lack of growth opportunities or management conservatism.

Market Momentum

FCUV is currently showing below-average momentum at 47/100, which may indicate weakening institutional interest or negative sentiment shifts. Revenue growth stands at 45.2% year-over-year, while a beta of 2.85 reflects its sensitivity to broader market moves. Investors should note that declining momentum can precede further price weakness, though contrarian opportunities sometimes emerge at these levels.

Balance Sheet Health

FOCUS UNIVERSAL INC. registers a low stability score of 6/100, indicating high volatility and potentially stressed financial conditions. Key stability metrics include a beta of 2.85 and a debt-to-equity ratio of 404.00x (sector avg: 0.2x). Stocks at this level carry elevated capital loss risk and may be unsuitable for conservative portfolios without careful risk management.

Institutional Risk Profile

The short interest score of 46/100 for FCUV suggests somewhat elevated bearish positioning by institutional traders. Specific risk factors include high market sensitivity (beta: 2.85), elevated leverage (D/E: 404.00x), micro-cap liquidity risk. With a $23M market cap (micro-cap), FOCUS UNIVERSAL INC. may experience above-average volatility. Investors should consider whether the short thesis has merit or if it creates a potential short-squeeze opportunity.

Sector Benchmark Analysis

FOCUS UNIVERSAL INC. is a micro-cap company in the Manufacturing sector, ranked #0 of 50 in its sector (100th percentile) and #3684 of 7,333 overall (50th percentile). Key comparisons include ROE of -1419.5% trailing the -1.9% sector median and operating margins of -2875.8% below the 2.5% sector average. This top-quartile standing reflects exceptional competitive strength relative to Manufacturing peers.

Comparative Research Mesh

FCUV VS S&P 500 (SPY)TOP MANUFACTURING PEERS

Strategic Alternatives

While FCUV currently exhibits a AVOID profile, superior opportunities exist within the MANUFACTURING sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.

View Top Manufacturing Alpha →

FCUV

FOCUS UNIVERSAL INC.

Business Summary

Operations

Location

Fundamental Spot Check

Valuation

Efficiency & Risk

Intelligence Feed

Focus Universal Inc. Launches Cost-Effective Commercial IoT for Four Sectors

Focus Universal Inc. Forms Sales Division for IoT and SEC Financial Reporting Solutions

Focus Universal Inc. Regains Compliance With Nasdaq Listing Requirements

Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket

Why Avaya Holdings Shares Are Trading Lower By 62%? Here Are 62 Stocks Moving In Friday's Mid-Day Session

Unlock Valuation Tools

Unlock Financial Statements

Unlock Governance & Ownership

Unlock Factor Analysis

Unlock Investment Thesis

Lateral Comparison Mesh

Comments

SEC Risk Factors

Unlock Performance & Technicals

Economic Moat Audit

Economic Value Creation

Margin Superiority

Reinvestment Efficiency

Growth Durability

Financial Resilience

Uncertainty Audit

01Executive Summary

02Strategy & Outlook

Risk / Reward Variance

Research Verdict

Related Stocks

Executive Summary

Business Quality

Intrinsic Valuation

Capital Reinvestment

Market Momentum

Balance Sheet Health

Institutional Risk Profile

Sector Benchmark Analysis

Comparative Research Mesh

Strategic Alternatives

Factor Dispersion Audit

Sector Variance Findings

Market Intel

Intelligence Feed

Focus Universal Inc. Launches Cost-Effective Commercial IoT for Four Sectors

Focus Universal Inc. Forms Sales Division for IoT and SEC Financial Reporting Solutions

Focus Universal Inc. Regains Compliance With Nasdaq Listing Requirements

Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket

Why Avaya Holdings Shares Are Trading Lower By 62%? Here Are 62 Stocks Moving In Friday's Mid-Day Session